This one-and-done heart-disease treatment just got a $1.3 billion endorsement from Eli Lilly
Up next
Author


Verve Therapeutics’ stock was rallying by a record 80% on Eli Lilly’s premium purchase price for the drug-development company.

You May Also Like
Harris campaign says it has raised nearly $50 million since Biden’s exit from White House race

Harris campaign says it has raised nearly $50 million since Biden’s exit from White House race

The Kamala Harris campaign has raised $49.6 million in grassroots donations since…

Treasury yields drop after Bessent picked for Treasury

Bond yields dropped on Monday on hopes that President-elect Donald Trump’s pick…
‘The China equity trade is back’ and here are the stocks to pick, says SocGen

‘The China equity trade is back’ and here are the stocks to pick, says SocGen

Analysts are getting increasingly more positive about Chinese stocks.

Thirsty families in Gaza eke out trickle of water

Hana Abu Awda and the 40 people with whom she shares a…